Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01035996 · ClinicalTrials.gov registry record

Dopamine Function and Reward Processing In Schizophrenia

A clinical trial of Schizophrenia, sponsored by National Institute on Drug Abuse (NIDA).

Completed
Registry status
159
Enrollment target
2
Study locations

NCT01035996 is a study of Schizophrenia that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 159 participants, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (27% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01035996, a study of Schizophrenia, has completed, sponsored by National Institute on Drug Abuse (NIDA).

COMPLETED
Registry status
159 participants
Enrollment target
2
Study locations

Study Summary

Background: \- Schizophrenia is associated with cognitive impairment in different parts of the brain, including those associated with learning and memory. The brain activity associated with these impairments, however, is poorly understood. Researchers are interested in studying how the brain chemical dopamine, which is involved in responding to incentives and rewards like money or food, works differently in the brains of people who have schizophrenia. Objectives: \- To study reward processing in individuals with schizophrenia who are taking different types of medication, compared with healthy volunteers. Eligibility: \- Individuals between 18 and 55 years of age who (a) have been diagnosed with schizophrenia/schizoaffective disorder and are taking the antipsychotic medication clozapine, (b), have been diagnosed with schizophrenia/schizoaffective disorder and are taking a different second-generation antipsychotic, or (c) are healthy volunteers. Design: * This study will involve one screening visit and one or more visits for testing and functional magnetic resonance imaging (fMRI) scans. During the screening visit, participants will complete questionnaires and provide information about their physical and psychological health. * Participants will receive training in the tasks to be performed at the scanning sessions during the screening visit. * During the fMRI scans, participants will complete one or two of four possible reward-based tasks: * A task that enables participants to win money based on their response to a target item. * A task that provides small amounts of juice over specific time intervals, followed by a procedure to be completed outside the scanner. * A task that involves choosing figures or shapes and winning money based on responses. * A game of chance involving predictions based on shapes shown on a screen. * Participants will also provide blood samples for research and testing.

Conditions Studied

Study Locations (2)

Maryland

  • University of Maryland, Baltimore - Baltimore
  • National Institute on Drug Abuse, Biomedical Research Center (BRC) - Baltimore

Trial Details

FieldValue
Enrollment Target 159 participants
Start Date 2005-03-08
Est. Completion 2017-02-13

What the Registry Record Tells You About NCT01035996

The ClinicalTrials.gov registry entry for NCT01035996 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 159 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (27% lower). The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Schizophrenia appearing as the primary indexed condition, and to 0 interventions.

NCT01035996 reports 2 study locations spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT01035996 about?

NCT01035996 is a clinical study titled "Dopamine Function and Reward Processing In Schizophrenia". Background: \- Schizophrenia is associated with cognitive impairment in different parts of the brain, including those associated with learning and memory. The brain activity associated with these impairments, however, is poorly understood. Researchers are interested in studying how the brain chemic...

What is the current status of trial NCT01035996?

This trial is currently completed. The enrollment target is 159 participants. The study started on 2005-03-08. Estimated completion is 2017-02-13.

What conditions does trial NCT01035996 study?

This clinical trial studies the following conditions: Schizophrenia.

Who is sponsoring clinical trial NCT01035996?

This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01035996 being conducted?

This trial has 2 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Schizophrenia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.